Stand out for this role — generate a tailored resume and cover letter in about a minute.
Legend Biotech USA, Inc. in Somerset, NJ, seeks an IT Asset Management Lead to plan and implement lifecycle strategies aligned with security policies.
This role manages CMDB asset inventory, audits, and full lifecycle processes from acquisition through decommissioning to optimize asset usage and cost. The position requires a Bachelor's degree in finance, IT, data analysis or related field, with duties including policy development, governance, subscription management, and collaboration with
Legend Biotech USA, Inc
IT Asset Management Lead
Legend Biotech USA, Inc. (Somerset, NJ) seeks IT Asset Management Lead to plan and implement IT Asset Lifecycle strategies aligned with business and security policies. Manage CMDB asset inventory, ensure data accuracy, conduct audits, and oversee full asset lifecycle processes from acquisition through decommissioning. Optimize usage and cost of IT Assets. Develop and enforce IT asset policies, processes, and governance controls. Manage IT subscriptions, supplier contracts, and drive ITAM best practices to optimize cost, reduce risk, and improve operational efficiency. Collaborate with business partners, suppliers, and audit teams to ensure compliance and alignment with organizational standards.
2101 Cottontail Lane, Somerset, NJ 08873
9:00 a.m. to 5:00 p.m. 5 days 40 hr/wk
$106,267 per year
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide.
Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize CARVYKTI® (ciltacabtagene autoleucel; cilta-cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma.
Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.
Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates.
It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.
Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company.
For information related to our privacy notice, please review: Legend Biotech Privacy Notice .